{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:01:36Z","timestamp":1773093696007,"version":"3.50.1"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T00:00:00Z","timestamp":1418083200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114110","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T18:55:17Z","timestamp":1418151317000},"page":"e114110","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Combined Efficacy of Cediranib and Quinacrine in Glioma Is Enhanced by Hypoxia and Causally Linked to Autophagic Vacuole Accumulation"],"prefix":"10.1371","volume":"9","author":[{"given":"Merryl R.","family":"Lobo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Yancey","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall L.","family":"Woltjer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin M.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,12,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev-pathol-121808-102109","article-title":"The pathobiology of glioma tumors","volume":"5","author":"CL Gladson","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e44372","DOI":"10.1371\/journal.pone.0044372","article-title":"Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy","volume":"7","author":"AD Joshi","year":"2012","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00063030-200923010-00003","article-title":"Targeted therapies for malignant glioma: progress and potential","volume":"23","author":"RW Mercer","year":"2009","journal-title":"BioDrugs"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1586\/ern.09.116","article-title":"Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies","volume":"9","author":"NG Thaker","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"G Bergers","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"RK Amaravadi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/0008-5472.CAN-11-3831","article-title":"Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma","volume":"72","author":"YL Hu","year":"2012","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1750-3639.2011.00544.x","article-title":"Autophagy in brain tumors: a new target for therapeutic intervention","volume":"22","author":"N Kaza","year":"2012","journal-title":"Brain Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/156652409788167131","article-title":"Regulation of autophagy through multiple independent hypoxic signaling pathways","volume":"9","author":"KM Rouschop","year":"2009","journal-title":"Curr Mol Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4161\/cbt.8.21.10416","article-title":"Autophagy can contribute to cell death when combining targeted therapy","volume":"8","author":"R Amaravadi","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200801099","article-title":"Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents","volume":"183","author":"M Degtyarev","year":"2008","journal-title":"J Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00109-011-0774-y","article-title":"Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma","volume":"89","author":"OK Mirzoeva","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1158\/1078-0432.CCR-12-1542","article-title":"Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy","volume":"19","author":"M Selvakumaran","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ijc.26374","article-title":"Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma","volume":"131","author":"S Shimizu","year":"2011","journal-title":"Int J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ijc.24030","article-title":"Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells","volume":"124","author":"T Shingu","year":"2009","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.1000248107","article-title":"Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST)","volume":"107","author":"A Gupta","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","first-page":"473","article-title":"Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent","volume":"12","author":"Y Geng","year":"2010","journal-title":"Neuro Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/neuonc\/not119","article-title":"Quinacrine synergistically enhances the antivascular and antitumor efficacy of cediranib in intracranial mouse glioma","volume":"15","author":"MR Lobo","year":"2013","journal-title":"Neuro Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1158\/0008-5472.CAN-04-4409","article-title":"AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer","volume":"65","author":"SR Wedge","year":"2005","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/00005072-199511000-00012","article-title":"A clone of the MOCH-1 glial tumor in culture: multiple phenotypes expressed under different environmental conditions","volume":"54","author":"CA Dyer","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1215\/S1152851705000074","article-title":"Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model","volume":"7","author":"EK Hellums","year":"2005","journal-title":"Neuro Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-009-9827-2","article-title":"Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target","volume":"92","author":"RL Jensen","year":"2009","journal-title":"J Neurooncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","article-title":"'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis","volume":"65","author":"Y Rong","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/S1152851704001115","article-title":"Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis","volume":"7","author":"B Kaur","year":"2005","journal-title":"Neuro Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mrm.21931","article-title":"High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI","volume":"61","author":"MM Pike","year":"2009","journal-title":"Magn Reson Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/1541-7786.MCR-06-0150","article-title":""Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways","volume":"4","author":"C Koumenis","year":"2006","journal-title":"Mol Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1038\/sj.onc.1207481","article-title":"Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD\/caspase-8 independent manner","volume":"23","author":"M Weinmann","year":"2004","journal-title":"Oncogene"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.1193497","article-title":"Autophagy and metabolism","volume":"330","author":"JD Rabinowitz","year":"2010","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1124\/dmd.109.028480","article-title":"Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: a model for the distribution of lipophilic cationic drugs to autophagic vacuoles","volume":"37","author":"F Marceau","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.bjc.6601605","article-title":"Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells","volume":"90","author":"H Takeuchi","year":"2004","journal-title":"Br J Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1247\/csf.23.33","article-title":"Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells","volume":"23","author":"A Yamamoto","year":"1998","journal-title":"Cell Struct Funct"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"TT Batchelor","year":"2007","journal-title":"Cancer Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"251231","DOI":"10.1155\/2010\/251231","article-title":"Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma","volume":"2010","author":"R Rahman","year":"2010","journal-title":"J Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1158\/0008-5472.CAN-11-2464","article-title":"Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion","volume":"72","author":"AG Sorensen","year":"2012","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nrc2501","article-title":"Hypoxia signalling through mTOR and the unfolded protein response in cancer","volume":"8","author":"BG Wouters","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4161\/cc.9.17.12908","article-title":"HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis","volume":"9","author":"B Chiavarina","journal-title":"Cell Cycle"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1074\/jbc.M800102200","article-title":"Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia","volume":"283","author":"H Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"GL Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejphar.2009.06.064","article-title":"Targeting the endoplasmic reticulum-stress response as an anticancer strategy","volume":"625","author":"SJ Healy","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response","volume":"40","author":"G Kroemer","year":"2010","journal-title":"Mol Cell"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1634\/theoncologist.12-12-1395","article-title":"Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas","volume":"12","author":"F Lefranc","year":"2007","journal-title":"Oncologist"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/MCB.25.3.1025-1040.2005","article-title":"Inhibition of macroautophagy triggers apoptosis","volume":"25","author":"P Boya","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc1738","article-title":"Lysosomes and autophagy in cell death control","volume":"5","author":"G Kroemer","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2334-4-53","article-title":"Pharmacokinetics of quinacrine in the treatment of prion disease","volume":"4","author":"L Yung","year":"2004","journal-title":"BMC Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.yexcr.2009.11.005","article-title":"Bortezomib induces autophagic death in proliferating human endothelial cells","volume":"316","author":"D Belloni","year":"2009","journal-title":"Exp Cell Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10456-010-9180-2","article-title":"The inhibition of autophagy potentiates anti-angiogenic effects of sulforaphane by inducing apoptosis","volume":"13","author":"T Nishikawa","year":"2010","journal-title":"Angiogenesis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/cbr.2010.0814","article-title":"Beclin1\/PI3K-mediated autophagy prevents hypoxia-induced apoptosis in EAhy926 cell line","volume":"26","author":"R Zhang","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fphar.2012.00094","article-title":"Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy","volume":"3","author":"BF Jordan","year":"2012","journal-title":"Front Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1593\/tlo.12400","article-title":"In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas","volume":"6","author":"O Martinho","year":"2013","journal-title":"Transl Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/03009734.2012.654860","article-title":"PDGF in gliomas: more than just a growth factor?","volume":"117","author":"N Lindberg","year":"2012","journal-title":"Ups J Med Sci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03009734.2012.665097","article-title":"PDGF and PDGF receptors in glioma","volume":"117","author":"I Nazarenko","year":"2012","journal-title":"Ups J Med Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1478-811X-9-13","article-title":"Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers","volume":"9","author":"R Ehsanian","year":"2011","journal-title":"Cell Commun Signal"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/onc.2008.460","article-title":"9-Aminoacridine-based anticancer drugs target the PI3K\/AKT\/mTOR, NF-kappaB and p53 pathways","volume":"28","author":"C Guo","year":"2009","journal-title":"Oncogene"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1073\/pnas.1105369108","article-title":"FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaB","volume":"108","author":"C Guo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref56","first-page":"135","article-title":"Multiple roles and therapeutic implications of Akt signaling in cancer","volume":"2","author":"E Calvo","year":"2009","journal-title":"Onco Targets Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:17:08Z","timestamp":1589019428000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114110"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,9]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114110","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,9]]}}}